Medical Company Receives Emergency Request From Malawi Health Ministry For Sleep Sickness Treatment

In a significant development that underscores the global challenge of combating neglected tropical diseases, PaxMedica, Inc. (NASDAQ: PXMD), a trailblazer in the development of treatments for neurological disorders, has stepped into the limelight with its recent response to an urgent plea from the Malawi Ministry of Health. The request? Emergency access to IV suramin, a critical drug in the battle against the fatal sleeping sickness, Trypanosoma brucei rhodesiense, transmitted by the tsetse fly. This urgent call comes amid emergent shortages of the drug, threatening to escalate into a potential humanitarian crisis in regions most vulnerable to the disease. Find out more about this urgent request and its implications. $PaxMedica(PXMD.US)$